"10.1371_journal.pone.0086663","plos one","2014-01-30T00:00:00Z","Christian P Kamm; Marwan El-Koussy; Sebastian Humpert; Oliver Findling; Yuliya Burren; Guido Schwegler; Filippo Donati; Martin Müller; Felix Müller; Johannes Slotboom; Ludwig Kappos; Yvonne Naegelin; Heinrich P Mattle; for the SWABIMS Study Group","Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland; Department of Diagnostic and Interventional Neuroradiology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland; Department of Neurology, Cantonal Hospital Aarau, Aarau, Switzerland; Department of Neurology, Spitalzentrum Biel, Biel, Switzerland; Department of Neurology, Cantonal Hospital Lucerne, Luzern, Switzerland; Department of Neurology, Cantonal Hospital, Muensterlingen, Muensterlingen, Switzerland; Department of Neurology, University Hospital, University of Basel, Basel, Switzerland","Conceived and designed the experiments: CPK HPM. Performed the experiments: CPK ME SH OF GS FD MM FM LK YN HPM. Analyzed the data: CPK ME YB JS HPM. Contributed reagents/materials/analysis tools: CPK ME YB JS HPM. Wrote the paper: CPK ME SH OF GS FD MM FM LK YN HPM.","The authors have read the journals policy and have the following conflicts: This study was funded by Bayer Schering Pharma (Switzerland) and Pfizer (Switzerland). Dr Kamm has received honoraria for lectures and consulting from Biogen-idec, Novartis, Bayer Schweiz AG, Teva, Merck-Serono, Genzyme and Pfizer. Dr Humpert has received honoraria for lectures from Biogen-Dompé, Merck-Serono and Novartis. Dr. Donati has received honoraria for consulting from Merck-Serono, Pfizer and Teva. Dr Findling, Dr von Bredow, Ms Burren, Dr Schwegler, Drs Müller, Dr Slotboom and Dr Naegelin have no competing interests. Prof Kappos received research support from the Swiss National Research Foundation, the Swiss MS Society, and from the Gianni Rubatto Foundation (Zurich); has served on scientific advisory boards and his Department at the University Hospital Basel has received research support from Acorda Therapeutics Inc., Actelion Pharmaceuticals Ltd, Abbott, AstraZeneca, Bayhill Therapeutics, Bayer Schering Pharma, Biogen Idec, Boehringer Ingelheim, Centocor Ortho Biotech Inc., Eisai Inc., Genzyme Corporation, GlaxoSmithKline, The Immune Response Corporation, MediciNova, Inc., Neurocrine Biosciences, Novartis, sanofi-aventis, Merck Serono, Roche, Teva Pharmaceutical Industries Ltd., UCB, and Wyeth. Prof Mattle has received honoraria for lectures and consulting from Bayer-Schering, Biogen-Dompé, Genzyme, Merck-Serono, TEVA, Sanofi-Aventis, Novartis and Pfizer. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","01","Christian P Kamm","CPK",14,FALSE,2,11,5,11,TRUE,TRUE,FALSE,0,NA,FALSE
